Gulino FA

No ORCID on file · 4 papers in corpus · active 2022-2025

Study types

  • article 1
  • letter 1
  • review 1

Condition tags

  • endometriosis 3
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • adenomyosis 1
  • dyspareunia 1
letter 2025
Reply to 'Critical appraisal of "Comparison of combined oral contraceptives and dienogest for endometriosis-associated pain"'
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2025.113945
article 2024
Comparative study on the effects of combined oral contraceptives and dienogest in women with endometriosis‑associated chronic pelvic pain
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2024.11.015

OBJECTIVE: To compare the effects of five combined oral contraceptives (COCs) - ethinylestradiol (EE) 30 μg/dienogest (DNG) 2 mg, EE 20 μg/drospirenone (DRSP) 3 mg, 17β-estradiol (E2) 1.5 mg/nomegestrol acetate (NomAc) 2.5 mg,estetrol (E4) …

review 2022
Anti-Mullerian Hormone (AMH) and adenomyosis: Mini-review of literature of the last 5 years
Frontiers in endocrinology ·doi:10.3389/fendo.2022.1014519

INTRODUCTION: Adenomyosis is a form of endometriosis characterized by the presence of endometrial tissue in the myometrium. The correlation between anti-Mullerian hormone (AMH) expression and adenomyosis is unclear. Few studies investigated…

2022
Understanding the limits of parametrial resection in radical hysterectomy: a randomized controlled trial.
Przeglad menopauzalny = Menopause review ·doi:10.5114/pm.2021.110598

IntroductionThe aim was to evaluate whether adding specific educational medical illustrations may help gynecologists to better understand the limits of parametrial resection in radical hysterectomy from type A to type C2. Study Design: rand…